Ashton Thomas Private Wealth, LLC
- SEC CIK
- 0002019663
- Latest filing
- Jul 29, 2026
CPRX holding history
Catalyst Pharmaceuticals, Inc. in every 13F filed by Ashton Thomas Private Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 37,458
- Value
- $1.18M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 37,458 | $1.18M | <0.1% | −834−2.2% | Reduced | Holders |
| Q1 2026 | 38,292 | $948.1K | <0.1% | +23,611+160.8% | Added | Holders |
| Q4 2025 | 14,681 | $342.7K | <0.1% | +315+2.2% | Added | Holders |
| Q3 2025 | 14,366 | $283.0K | <0.1% | −1,645−10.3% | Reduced | Holders |
| Q2 2025 | 16,011 | $347.4K | <0.1% | +2,997+23.0% | Added | Holders |
| Q1 2025 | 13,014 | $315.6K | <0.1% | +899+7.4% | Added | Holders |
| Q4 2024 | 12,115 | $252.8K | <0.1% | +276+2.3% | Added | Holders |
| Q3 2024 | 11,839 | $235.4K | <0.1% | +84+0.7% | Added | Holders |
| Q2 2024 | 11,755 | $182.1K | <0.1% | +342+3.0% | Added | Holders |
| Q1 2024 | 11,413 | $181.9K | <0.1% | +1,014+9.8% | Added | Holders |
| Q4 2023 | 10,399 | $174.8K | <0.1% | −190−1.8% | Reduced | Holders |
| Q3 2023 | 10,589 | $123.8K | <0.1% | +190+1.8% | Added | Holders |
| Q2 2023 | 10,399 | $139.8K | <0.1% | +10,399 | New | Holders |